Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Heart Rhythm Society legislative advocacy group raising funds for electrophysiology
This week, Heart Rhythm Advocates announced its establishment and called on cardiologists and EPs to support its efforts with membership and joining committees to guide efforts.
FDA chooses not to approve new nasal spray for heart rhythm issues
Etripamil's journey toward FDA approval hit a roadblock. The agency requested additional information on the drug, including a new facility inspection, in a response letter sent to Milestone Pharmaceuticals.
Abbott gains CE mark approval for Volt PFA system
The approval, which Abbott said arrived earlier than expected, came after regulators reviewed data from a 2024 clinical trial.
Enabling X-ray-free ablation procedures in the EP lab
Exposure to scatter radiation and orthopedic issues related to years of wearing lead aprons during long EP procedures has led electrophysiologists to seek out new ways to reduce the need for angiographic X-ray.
The evolution of RF technology to reduce complications and improve outcomes
Advancements in radiofrequency (RF) catheter ablation technology have been incremental over the past 30 years in efforts to improve safety, procedural efficiency and patient outcomes. While some newer technologies have gained a lot of attention in electrophysiology (EP) over the past several years, RF remains the solid frontline treatment.

AFib after surgery could be a warning sign of heart failure

Researchers studied data from more than three million patients, including approximately 76,000 who underwent heart surgery.

Two examples of new left atrial appendage occluders (LAAO), the Conformal omn left and the Laminar on the right. evi Nair, MD, FACC, FHRS, director of cardiac electrophysiology at St. Bernard's Healthcare, Jonesboro, Arkansas, explains some of the recent advances in transcatheter left atrial appendage (LAA) occlusion technology at the 2022 Transcatheter Valve Therapeutics (TVT) Structural Heart Summit. #TVT #TVT2020 #LAA #LAAO #EPeeps

VIDEO: Advances in left atrial appendage occlusion technology

Devi Nair, MD, director of cardiac electrophysiology at St. Bernard's Healthcare, Jonesboro, Arkansas, explains some of the recent advances in transcatheter left atrial appendage (LAA) occlusion technology at the 2022 Transcatheter Valve Therapeutics (TVT) Structural Heart Summit.

What peridevice leaks after LAAO mean for patient health

The study's authors reviewed data from more than 50,000 patients, presenting their findings in JACC: Clinical Electrophysiology.

3D cardiac modeling solution for VT ablation receives FDA clearance

The new software solution was designed with ventricular tachycardia ablation and other cardiac ablation procedures in mind.

Left bundle branch block after TAVR hurts outcomes, even when no permanent pacemaker is required

Researchers tracked data from more than 2,000 TAVR patients, focusing on cardiovascular mortality and hospitalizations for heart failure.

State of the industry: 7 big takeaways from a new report on salaries and job satisfaction in cardiology

With physician burnout on the rise and a massive physician shortage on the way, it’s more important now than ever to keep a close eye on how the country’s cardiologists—and their colleagues—are being paid.

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance.

Real-world Watchman patients experiencing fewer complications after LAAO than seen in clinical trials

The study's authors compared findings from the PROTECT-AF and PREVAIL clinical trials with data from the NCDR LAAO Registry, focusing on short-term and long-term outcomes.

Electrophysiology

Heart Rhythm Society legislative advocacy group raising funds for electrophysiology

FDA chooses not to approve new nasal spray for heart rhythm issues

Abbott gains CE mark approval for Volt PFA system

Enabling X-ray-free ablation procedures in the EP lab

The evolution of RF technology to reduce complications and improve outcomes